1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Nymox Pharmaceutical Corp (NYMX)

  7. Nymox Pharmaceutical Corp (NYMX) Financials

NYMX

Nymox Pharmaceutical Corp
0.3776
0.0276 (7.89%)
Upgrade to Real-Time

Nymox Pharmaceutical Corporation (NYMX) Fundamentals
Nymox Pharmaceutical Corp is a biopharmaceutical company focused on developing its drug candidate, NX-1207, for the treatment of BPH and the treatment of low-grade localized prostate cancer. It markets NicAlert and TobacAlert tests that use urine or saliva to detect use of tobacco products. It operates in a single segment, which is research and development of products for the aging population. The company's geographical segments include Canada, United States, and Europe.
SHARE INFORMATION
Market Cap$ 34,088,002
Shares Outstanding90,515,140
Float48,376,644
Percent Float53.45%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -0.15
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions121
Institutional Holdings Date2021-07-31
Institutional Bought Previous 3 Months516,559
Institutional Holdings Percent7.9%
Institutional Sold Previous 3 Months3,019,108
Insider Holdings Date2023-02-28
Insider Bought Previous 3 Months-
Insider Holdings Percent31.2
Insider Sold Previous 3 Months-
Insider Shares Owned28,207,313
TRADING INFO
52 Week High$ 1.49
52 Week Low$ 0.19
52 Week High Change$ -70.81
21 Day Moving Average$ 0.365
21 Day Extended Moving Average$ 0.379224
50 Day Moving Average$ 0.4092
50 Day Extended Moving Average$ 0.389487
200 Day Moving Average$ 0.393665
200 Day Extended Moving Average$ 0.532048
10 Day Average Volume35,423
20 Day Average Volume44,453
30 Day Average Volume56,026
50 Day Average Volume54,025
Alpha-0.018169
Beta0.7500
Standard Deviation0.217161
R20.034591
7 Day Price Change$ 0.0214
7 Day Percent Change6.02%
21 Day Price Change$ 0.0201
21 Day Percent Change5.64%
30 Day Price Change$ 0.0266
30 Day Percent Change7.6%
Month to Date Price Change$ 0.0266
Month to Date Percent Change7.6%
Quarter to Date Price Change$ 0.0533
Quarter to Date Percent Change16.49%
180 Day Price Change$ -0.0133
180 Day Percent Change-3.41%
200 Day Price Change$ 0.0011
200 Day Percent Change0.29%
Year to Date Price Change$ 0.0533
Year to Date Percent Change16.49%

Nymox Pharmaceutical Corporation (NYMX) Key Ratios

PROFITABILITY
EBIT Margin222,500.0%
EBITDA Margin217,460.0%
Pre-Tax Profit Margin-98,081.0%
Profit Margin Count0.0%
Gross Margin100.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book46.40
Total Debt To Equity0.30
Int Coverage-180.80
Current Ratio1.20
Leverage Ratio5.20
Quick Ratio1.20
Long Term Debt To Capital0.01
VALUATION MEASURES
PE Ratio-3.90
Enterprise Value$ 33,385,098
Price to Sales0.00
Price to Free Cash-9.10
PE High Last 5 Years-14.50
Price To Book46.40
Price To Cash Flow0.00
PE Low Last 5 Years-9.50
Price to Tangible Book46.40
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-251.34
Return on Equity-761.30
Return on Capital-496.12

Nymox Pharmaceutical Corporation (NYMX) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorThayer O'Neal Company, LLC
CEOPaul Averback
Emplyoees3
Last AuditUE
CIK0001018735
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
AddressBay & Deveaux Streets
Nassau,
Websitehttps://www.nymox.com
Facsimile+1 514 332-2227
Telephone+1 800 936-9669
Email-
Your Recent History
NASDAQ
NYMX
Nymox Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20230330 20:57:40